Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Reprod Toxicol. 2015 Feb 26;52:93–100. doi: 10.1016/j.reprotox.2015.02.002

Table 2.

Characteristics of included and excluded participants who reported using paraben-containing medications within 24 hours of at least one urine sample

Subject characteristic Included
N=11
Excluded1
N=7
P2
Gender 0.53
Female 10 (90.9) 5 (71.4)
Male 1 (9.1) 2 (28.6)
Age—mean ± SD 36.1 ± 3.4 36.2 ± 3.8 0.95
BMI—mean ± SD 25.0 ± 3.6 28.8 ± 5.7 0.11
<25 6 (54.5) 1 (14.3) 0.24
25 – <30 4 (36.4) 4 (57.1)
≥30 1 (9.1) 2 (28.6)
Race --
White 11 (100.0) 7 (100.0)
Smoking status 0.01
Never 11 (100.0) 3 (42.9)
Ever 0 (0.0) 4 (57.1)
  Former -- 3 (42.9)
  Current -- 1 (14.3)

SD, standard deviation; BMI, body mass index

Data are presented as n (%) unless otherwise specified

1

Participants were excluded due to lack of available urinary paraben concentration measurements (n=4) or due to a lack of unexposed samples (n=3)

2

P-values were obtained using Student’s t-test for continuous variables and Fisher’s exact test for categorical variables